Annual report pursuant to Section 13 and 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.7.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Year Ended
 December 31,
Franchised clinics:   2016   2015
Clinics in operation at beginning of period    
265
      
242
  
Opened during the period    
56
      
54
  
Acquired during the period    
(6
 )    
(24
 )
Closed during the period    
(6
 )    
(7
 )
Clinics in operation at the end of the period    
309
      
265
  
    Year Ended
 December 31,
Company-owned or managed clinics:   2016   2015
Clinics in operation at beginning of period    
47
      
4
  
Opened during the period    
8
      
21
  
Acquired during the period    
6
      
24
  
Closed during the period    
-
      
(2
 )
Clinics in operation at the end of the period    
61
      
47
  
                 
Total clinics in operation at the end of the period    
370
      
312
  
                 
Clinic licenses sold but not yet developed    
115
      
168
  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Year Ended
 December 31,
    2016   2015
         
Net loss   $
(15,173,872
 )   $
(8,797,321
 )
                 
Weighted average common shares outstanding - basic    
12,696,649
      
10,042,001
  
Effect of dilutive securities:                
Stock options    
-
      
-
  
Weighted average common shares outstanding - diluted    
12,696,649
      
10,042,001
  
                 
Basic and diluted loss per share   $
(1.20
 )   $
(0.88
 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Year Ended
 December 31,
    2016   2015
Unvested restricted stock    
92,415
      
339,288
  
Stock options    
953,075
      
477,459
  
Warrants    
90,000
      
90,000